annual current liabilities:
$42.99B-$4.80B(-10.04%)Summary
- As of today (May 30, 2025), PFE annual total current liabilities is $42.99 billion, with the most recent change of -$4.80 billion (-10.04%) on December 31, 2024.
- During the last 3 years, PFE annual current liabilities has risen by +$324.00 million (+0.76%).
- PFE annual current liabilities is now -10.04% below its all-time high of $47.79 billion, reached on December 31, 2023.
Performance
PFE Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$36.45B-$6.54B(-15.22%)Summary
- As of today (May 30, 2025), PFE quarterly total current liabilities is $36.45 billion, with the most recent change of -$6.54 billion (-15.22%) on March 29, 2025.
- Over the past year, PFE quarterly current liabilities has dropped by -$4.04 billion (-9.99%).
- PFE quarterly current liabilities is now -23.73% below its all-time high of $47.79 billion, reached on December 31, 2023.
Performance
PFE quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PFE Current liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -10.0% | -10.0% |
3 y3 years | +0.8% | -7.2% |
5 y5 years | +15.3% | +7.6% |
PFE Current liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -10.0% | +2.0% | -23.7% | +17.1% |
5 y | 5-year | -10.0% | +65.9% | -23.7% | +40.6% |
alltime | all time | -10.0% | +4380.1% | -23.7% | +3698.3% |
PFE Current liabilities History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $36.45B(-15.2%) |
Dec 2024 | $42.99B(-10.0%) | $42.99B(-0.5%) |
Sep 2024 | - | $43.21B(-1.4%) |
Jun 2024 | - | $43.82B(+8.2%) |
Mar 2024 | - | $40.50B(-15.3%) |
Dec 2023 | $47.79B(+13.4%) | $47.79B(+53.5%) |
Sep 2023 | - | $31.14B(-10.1%) |
Jun 2023 | - | $34.65B(-5.2%) |
Mar 2023 | - | $36.56B(-13.2%) |
Dec 2022 | $42.14B(-1.2%) | $42.14B(-4.9%) |
Sep 2022 | - | $44.31B(-6.5%) |
Jun 2022 | - | $47.41B(+20.7%) |
Mar 2022 | - | $39.27B(-8.0%) |
Dec 2021 | $42.67B(+64.6%) | $42.67B(+2.1%) |
Sep 2021 | - | $41.80B(+17.2%) |
Jun 2021 | - | $35.66B(+33.8%) |
Mar 2021 | - | $26.65B(+2.8%) |
Dec 2020 | $25.92B(-30.5%) | $25.92B(-24.1%) |
Sep 2020 | - | $34.15B(+4.4%) |
Jun 2020 | - | $32.72B(-3.4%) |
Mar 2020 | - | $33.89B(-9.2%) |
Dec 2019 | $37.30B(+17.1%) | $37.30B(+0.9%) |
Sep 2019 | - | $36.97B(+15.4%) |
Jun 2019 | - | $32.03B(+8.9%) |
Mar 2019 | - | $29.42B(-7.6%) |
Dec 2018 | $31.86B(+4.7%) | $31.86B(+9.8%) |
Sep 2018 | - | $29.01B(-9.8%) |
Jun 2018 | - | $32.16B(+17.5%) |
Mar 2018 | - | $27.36B(-10.1%) |
Dec 2017 | $30.43B(-2.2%) | $30.43B(+7.8%) |
Sep 2017 | - | $28.22B(+3.8%) |
Jun 2017 | - | $27.18B(+9.3%) |
Mar 2017 | - | $24.86B(-20.1%) |
Dec 2016 | $31.11B(+5.8%) | $31.11B(-10.5%) |
Sep 2016 | - | $34.76B(+8.3%) |
Jun 2016 | - | $32.10B(+11.7%) |
Mar 2016 | - | $28.73B(-2.3%) |
Dec 2015 | $29.40B(+36.2%) | $29.40B(+5.6%) |
Sep 2015 | - | $27.84B(+15.3%) |
Jun 2015 | - | $24.14B(+19.4%) |
Mar 2015 | - | $20.22B(-6.3%) |
Dec 2014 | $21.59B(-7.6%) | $21.59B(+8.4%) |
Sep 2014 | - | $19.92B(-9.2%) |
Jun 2014 | - | $21.94B(-11.5%) |
Mar 2014 | - | $24.79B(+6.1%) |
Dec 2013 | $23.37B(-19.9%) | $23.37B(+14.7%) |
Sep 2013 | - | $20.37B(-13.1%) |
Jun 2013 | - | $23.45B(-14.9%) |
Mar 2013 | - | $27.54B(-5.6%) |
Dec 2012 | $29.19B(+1.0%) | $29.19B(+0.2%) |
Sep 2012 | - | $29.13B(-5.4%) |
Jun 2012 | - | $30.80B(+13.7%) |
Mar 2012 | - | $27.09B(-6.3%) |
Dec 2011 | $28.91B(+1.0%) | $28.91B(+3.8%) |
Sep 2011 | - | $27.86B(-8.6%) |
Jun 2011 | - | $30.47B(+4.5%) |
Mar 2011 | - | $29.17B(+2.0%) |
Dec 2010 | $28.61B(-23.1%) | $28.61B(+18.4%) |
Sep 2010 | - | $24.17B(-2.1%) |
Jun 2010 | - | $24.68B(-4.8%) |
Mar 2010 | - | $25.92B(-30.4%) |
Dec 2009 | $37.23B(+37.8%) | $37.23B(+55.2%) |
Sep 2009 | - | $23.99B(-8.1%) |
Jun 2009 | - | $26.11B(+11.9%) |
Mar 2009 | - | $23.34B(-13.6%) |
Dec 2008 | $27.01B(+23.7%) | $27.01B(+25.6%) |
Sep 2008 | - | $21.50B(-7.3%) |
Jun 2008 | - | $23.19B(+7.0%) |
Mar 2008 | - | $21.68B(-0.7%) |
Dec 2007 | $21.84B(-1.2%) | $21.84B(+52.4%) |
Sep 2007 | - | $14.33B(-5.3%) |
Jun 2007 | - | $15.14B(+13.8%) |
Mar 2007 | - | $13.30B(-39.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2006 | $22.10B(-22.2%) | $22.10B(+24.9%) |
Sep 2006 | - | $17.69B(-11.8%) |
Jun 2006 | - | $20.05B(+1.9%) |
Mar 2006 | - | $19.67B(-30.8%) |
Dec 2005 | $28.41B(+7.4%) | $28.41B(+39.3%) |
Sep 2005 | - | $20.39B(-9.6%) |
Jun 2005 | - | $22.57B(-22.0%) |
Mar 2005 | - | $28.95B(+9.4%) |
Dec 2004 | $26.46B(+10.7%) | $26.46B(+4.8%) |
Sep 2004 | - | $25.24B(+0.3%) |
Jun 2004 | - | $25.16B(+2.1%) |
Mar 2004 | - | $24.64B(+3.0%) |
Dec 2003 | $23.91B(+28.9%) | $23.91B(+10.4%) |
Sep 2003 | - | $21.66B(-2.2%) |
Jun 2003 | - | $22.16B(+18.1%) |
Mar 2003 | - | $18.75B(+1.1%) |
Dec 2002 | $18.55B(+35.2%) | $18.55B(+0.8%) |
Sep 2002 | - | $18.40B(+12.8%) |
Jun 2002 | - | $16.32B(+10.8%) |
Mar 2002 | - | $14.73B(+7.3%) |
Dec 2001 | $13.73B(+14.6%) | $13.73B(+5.3%) |
Sep 2001 | - | $13.04B(+8.8%) |
Jun 2001 | - | $11.98B(+10.2%) |
Mar 2001 | - | $10.87B(-9.2%) |
Dec 2000 | $11.98B(+0.7%) | $11.98B(-2.9%) |
Sep 2000 | - | $12.34B(+1.0%) |
Jun 2000 | - | $12.22B(+63.4%) |
Mar 2000 | - | $7.48B(-37.1%) |
Dec 1999 | $11.90B(+65.4%) | $11.90B(+30.8%) |
Sep 1999 | - | $9.09B(+3.2%) |
Jun 1999 | - | $8.81B(+13.6%) |
Mar 1999 | - | $7.75B(+7.8%) |
Dec 1998 | $7.19B(+44.0%) | $7.19B(-0.9%) |
Sep 1998 | - | $7.26B(+18.3%) |
Jun 1998 | - | $6.14B(+8.0%) |
Mar 1998 | - | $5.68B(+13.8%) |
Dec 1997 | $4.99B(-11.5%) | $4.99B(-13.6%) |
Sep 1997 | - | $5.78B(-10.0%) |
Jun 1997 | - | $6.42B(+11.1%) |
Mar 1997 | - | $5.78B(+2.5%) |
Dec 1996 | $5.64B(+8.7%) | $5.64B(-9.0%) |
Sep 1996 | - | $6.20B(+6.0%) |
Jun 1996 | - | $5.85B(+6.7%) |
Mar 1996 | - | $5.48B(+5.7%) |
Dec 1995 | $5.19B(+7.5%) | $5.19B(-10.6%) |
Sep 1995 | - | $5.80B(-5.0%) |
Jun 1995 | - | $6.10B(+5.6%) |
Mar 1995 | - | $5.78B(+19.7%) |
Dec 1994 | $4.83B(+40.1%) | $4.83B(+16.6%) |
Sep 1994 | - | $4.14B(-3.4%) |
Jun 1994 | - | $4.29B(+14.3%) |
Mar 1994 | - | $3.75B(+8.9%) |
Dec 1993 | $3.44B(+7.0%) | $3.44B(-16.9%) |
Sep 1993 | - | $4.15B(+1.2%) |
Jun 1993 | - | $4.10B(+13.3%) |
Mar 1993 | - | $3.62B(+12.4%) |
Dec 1992 | $3.22B(-5.9%) | $3.22B(-0.2%) |
Sep 1992 | - | $3.22B(+2.1%) |
Jun 1992 | - | $3.16B(+3.7%) |
Mar 1992 | - | $3.05B(-10.9%) |
Dec 1991 | $3.42B(+9.7%) | $3.42B(+6.0%) |
Sep 1991 | - | $3.23B(-1.0%) |
Jun 1991 | - | $3.26B(+15.4%) |
Mar 1991 | - | $2.83B(-9.3%) |
Dec 1990 | $3.12B(+7.1%) | $3.12B(+16.5%) |
Sep 1990 | - | $2.68B(+3.8%) |
Jun 1990 | - | $2.58B(+9.6%) |
Mar 1990 | - | $2.35B(-19.2%) |
Dec 1989 | $2.91B(+24.2%) | $2.91B(+24.2%) |
Dec 1988 | $2.34B(+19.8%) | $2.34B(+19.8%) |
Dec 1987 | $1.96B(+67.1%) | $1.96B(+67.1%) |
Dec 1986 | $1.17B(+22.0%) | $1.17B(+22.0%) |
Dec 1985 | $959.70M(-11.4%) | $959.70M(-11.4%) |
Dec 1984 | $1.08B | $1.08B |
FAQ
- What is Pfizer annual total current liabilities?
- What is the all time high annual current liabilities for Pfizer?
- What is Pfizer annual current liabilities year-on-year change?
- What is Pfizer quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Pfizer?
- What is Pfizer quarterly current liabilities year-on-year change?
What is Pfizer annual total current liabilities?
The current annual current liabilities of PFE is $42.99B
What is the all time high annual current liabilities for Pfizer?
Pfizer all-time high annual total current liabilities is $47.79B
What is Pfizer annual current liabilities year-on-year change?
Over the past year, PFE annual total current liabilities has changed by -$4.80B (-10.04%)
What is Pfizer quarterly total current liabilities?
The current quarterly current liabilities of PFE is $36.45B
What is the all time high quarterly current liabilities for Pfizer?
Pfizer all-time high quarterly total current liabilities is $47.79B
What is Pfizer quarterly current liabilities year-on-year change?
Over the past year, PFE quarterly total current liabilities has changed by -$4.04B (-9.99%)